Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study

H.M. Blommestein, D.E. Issa, M. Pompen, G. Ten Hoor, M. Hogendoorn, P. Joosten, S. Zweegman, P.C. Huijgens, C.A. Uyl-de Groot

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)398-406
JournalEuropean journal of haematology
Issue number5
Publication statusPublished - 2014

Cite this